- Home
- FBIZ vs PRTA Comparison
FBIZ vs PRTA Comparison
Compare FBIZ & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIZ
- PRTA
- Stock Information
- Founded
- FBIZ 1909
- PRTA 2012
- Country
- FBIZ United States
- PRTA Ireland
- Employees
- FBIZ N/A
- PRTA N/A
- Industry
- FBIZ Major Banks
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- FBIZ Finance
- PRTA Health Care
- Exchange
- FBIZ Nasdaq
- PRTA Nasdaq
- Market Cap
- FBIZ 390.3M
- PRTA 366.6M
- IPO Year
- FBIZ N/A
- PRTA N/A
- Fundamental
- Price
- FBIZ $49.54
- PRTA $8.25
- Analyst Decision
- FBIZ Buy
- PRTA Buy
- Analyst Count
- FBIZ 3
- PRTA 10
- Target Price
- FBIZ $58.67
- PRTA $24.29
- AVG Volume (30 Days)
- FBIZ 36.8K
- PRTA 1.0M
- Earning Date
- FBIZ 07-24-2025
- PRTA 08-04-2025
- Dividend Yield
- FBIZ 2.33%
- PRTA N/A
- EPS Growth
- FBIZ 22.50
- PRTA N/A
- EPS
- FBIZ 5.60
- PRTA N/A
- Revenue
- FBIZ $150,952,000.00
- PRTA $10,341,000.00
- Revenue This Year
- FBIZ $17.98
- PRTA N/A
- Revenue Next Year
- FBIZ $8.26
- PRTA $122.46
- P/E Ratio
- FBIZ $8.90
- PRTA N/A
- Revenue Growth
- FBIZ 8.24
- PRTA N/A
- 52 Week Low
- FBIZ $41.01
- PRTA $4.32
- 52 Week High
- FBIZ $56.46
- PRTA $22.83
- Technical
- Relative Strength Index (RSI)
- FBIZ 51.02
- PRTA 75.08
- Support Level
- FBIZ $49.11
- PRTA $7.39
- Resistance Level
- FBIZ $50.21
- PRTA $8.17
- Average True Range (ATR)
- FBIZ 1.01
- PRTA 0.45
- MACD
- FBIZ 0.25
- PRTA 0.09
- Stochastic Oscillator
- FBIZ 84.45
- PRTA 95.07
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.